H.C. Wainwright lowered the firm’s price target on CareDx (CDNA) to $25 from $26 and keeps a Neutral rating on the shares following the Q4 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA: